1772P Characterisation of a DNA repair deficiency (DRD) biomarker phenotype in metastatic urothelial carcinoma (mUC) within the ATLANTIS clinical trial platform.

Authors :: Crabb, S.J.
Dempsey, L.
Soulis, E.
Hinsley, S.
Song, Y.P.
Barber, J.
Frew, J.
Gale, J.
Faust, G.
Brock, S.
McGovern, U.B.
Parikh, O.A.
Enting, D.
Sundar, S.
Ratnayake, G.
Lees, K.
Hussain, S.A.
Powles, T.B.
Jones, R.
Tapper, W.
Source :: Annals of Oncology. 2022 Supplement 7, Vol. 33, pS1348-S1348. 1p.
Publication Year :: 2022

Subjects :: *DNA repair
*TRANSITIONAL cell carcinoma
*CLINICAL trials
*BIOMARKERS
*PHENOTYPES

Full Text Access

Tools